Sökresultat

The DEuteration and MAcromolecular Xtallisation (DEMAX) platform of the European Spallation Source ERIC (ESS) moved into Biology House A at Lund University and is now co-localised with the Lund Protein Production Platform (LP3). DEMAX (external website) and LP3 are collaborating to coordinate their efforts to develop cost-effective production of deuterated biomaterials (lipids and proteins) for ne

https://www.lp3.lu.se/article/partnership-between-lp3-and-demax - 2025-10-03

A Bioscreen C system for microbiological growth studies is now available at LP3. The Bioscreen C (external website) can incubate, shake, and measure the turbidity (OD) of up to 200 samples simultaneously. 

https://www.lp3.lu.se/article/new-system-microbiological-growth-monitoring - 2025-10-03

LP3 is part of the Protein Production Network Sweden (PPNS) that aims to make multiple protein expression hosts, methodologies and competence in protein production available to the Swedish academic life science community. Collaboration between Swedish protein production sites is crucial in order to solve complex scientific questions and in a pilot effort to test a new joint approach, five proteins

https://www.lp3.lu.se/article/protein-production-network-sweden-pilot-expression-screen-completed - 2025-10-03

LP3 is taking part in the formation of a network of Swedish protein production facilities together with Protein Science Facility at Karolinska Institutet/SciLifeLab (external website) Mammalian Protein Expression at Göteborg University (external website) Protein Expertise Platform at Umeå University (external website) Drug Discovery and Development platform at SciLifeLab (external website) The net

https://www.lp3.lu.se/article/network-swedish-protein-production-facilities - 2025-10-03

Right now LP3 is in the process of establishing the Baculovirus Expression Vector System (BEVS) – a system for expression of recombinant proteins in insect cells. This system will complement the current LP3 capabilities to express proteins in bacteria and yeast. The BEVS, being a eukaryotic expression system, has its strength in producing proteins from higher eukaryotic organisms that have failed

https://www.lp3.lu.se/article/eukaryotic-expression-system - 2025-10-03

Under den pågående CoViD-19 pandemin har förståelsen för virusets proteiner varit en central del i forskningen om SARS-CoV-2, eftersom det är genom proteinkontakter som viruset invaderar människans celler. På flera universitet i Sverige finns faciliteter som producerar proteiner för olika forskningsprojekt och som ingår i ett nätverk kallat Protein Produktion Sverige (PPS). PPS har genom sitt nati

https://www.lp3.lu.se/article/med-proteiner-som-nycklar-till-sars-cov-2-sa-har-vi-lart-oss-mer-om-viruset - 2025-10-03

By fragment screening using x-ray crystallography we identified four ligands revealing ligand-binding sites in conserved interfaces between SARS-CoV-2 nsp10 and nsp14/nsp16. The nsp14/10 interaction is weak and therefore could be disrupted by small molecules. In a collaborative effort, the Lund Protein Production Platform (LP3), the FragMAX platform at the BioMAX beamline of the MAX IV laboratory,

https://www.lp3.lu.se/article/fragmax-library-identifies-ligand-binding-sites-nsp10-and-nsp1416-interfaces-sars-cov-2 - 2025-10-03

The new protein production platform will start in the beginning 2022 and is a co-operation between five Swedish universities. A new nationally distributed infrastructure - Protein Production Sweden or Proteinproduktion Sverige (PPS) in Swedish, will start up in the beginning of 2022. This is made possible thanks to a five-year-grant (until 2026) from the Swedish Research Council. Together, five un

https://www.lp3.lu.se/article/new-national-infrastructure-protein-production-sweden-pps - 2025-10-03

LP3 extends its portfolio of machines available for biophysical analysis by welcoming the OMNISEC system from Malvern Panalytical. Thanks to a grant from Olle Engkvisits foundation to Prof. Anders Malmström (Experimental Medical Sciences, Lund University), we now host a state of the art multi-detection size exclusion chromatography (SEC) system: OMNISEC. The OMNISEC system is now available to user

https://www.lp3.lu.se/article/now-lp3-absolute-molecular-weight-determination-proteins - 2025-10-03

Wolfgang Knecht, head of LP3 presented the capabilities of LP3 in biophysics and protein structure determination at the first Swedish national PI-meeting in Biochemistry, Biophysics and Molecular Biology (external webpage). The meeting was jointly organized by the Swedish Society for Biochemistry, Biophysics and Molecular Biology, SFBBM(external webpage, in Swedish) and the Swedish National Commit

https://www.lp3.lu.se/article/lp3-presented-swedish-national-pi-meeting-biochemistry-biophysics-and-molecular-biology - 2025-10-03

To strengthen the engagement of the Swedish scientific community in ESS, Sweden has now officially become part of the ESS in-kind community with four projects selected by ESS and the Swedish Research Council. To strengthen the engagement of the Swedish scientific community in the European Spallation Source (ESS), Sweden has now officially become part of the ESS in-kind community with a number of c

https://www.lp3.lu.se/article/sweden-enters-kind-agreement-ess-lp3-contributes-deuteration-lab-services - 2025-10-03

The Deuteration Network (DeuNet) is an international network which aims to facilitate access to deuteration services. The Deuteration Network (DeuNet) (external webpage) is an international network of deuteration facilities and laboratories which aims to facilitate access to deuteration services and customised deuterium labelling of molecules and biomolecules for use in neutron research and in oth

https://www.lp3.lu.se/article/new-deunet-webpage-now-launched - 2025-10-03

All staff from LP3, which is one out of five nodes in the PPS national infrastructure, participated. The distributed national research infrastructure Protein Production Sweden (PPS, see external website) did meet for its second annual staff retreat at Ljunglöfska slottet in Stockholm. The 25 staff researchers of PPS attending used the two day meeting (28/29th September 2023) to discuss and reflect

https://www.lp3.lu.se/article/annual-pps-retreat-stockholm - 2025-10-03

Recently, a book chapter with protocols for the Baculovirus Expression Vector System in insect cells was published by LP3. Lund Protein Production Platform (LP3) has recently published its standard operating procedures for recombinant protein expression using the Baculovirus Expression Vector System (BEVS) in insect cells. Read the full book chapter here at Springer Link (external website)LP3 prov

https://www.lp3.lu.se/article/new-publication-about-bevs-lp3 - 2025-10-03

Members of the board and scientific committee of PPS, Sabine Suppmann and Kim Remans, respectively are among the authors of a new review in Star Protocols about expression systems for recombinant protein production. The overview is based on a survey with 60 leading experts in protein production about their experiences and practices in using different expression systems for recombinant protein prod

https://www.lp3.lu.se/article/guide-choosing-expression-system-recombinant-proteins - 2025-10-03

Lund Protein Production Platform (LP3) is featured in EUGLOHRIA Talks and EUGLOHRIA Virtual Tours approaching audiences with interactive and innovative content and an interview with the head of LP3, Dr. Wolfgang Knecht, is now available on the EUGLOHRIA homepage. The European University Alliance for Global Health – Transformation through Joint Research and Innovation Action (EUGLOHRIA, external li

https://www.lp3.lu.se/article/lund-protein-production-platform-featured-euglohria-talks-and-euglohria-virtual-tours - 2025-10-03

At the first 2024 management meeting, SciLifeLab Lund welcomed LP3 as a new local core facility. The aim of the local SciLifeLab sites in Umeå, Linköping, Gothenburg and Lund is to bring national infrastructure activities closer to the research communities at these locations, and to contribute to increased synergies and collaborations with multiple stakeholders.SciLifeLab Lund (external webpage) w

https://www.lp3.lu.se/article/lp3-newest-local-core-facility-scilifelab-lund - 2025-10-03

LP3 with Celeste Sele presented its capabilities in Protein Characterisation, Crystallisation and Structure Determination at the 35th MAX IV user meeting in Lund (external homepage). LP3 is harboring a local node of Protein Production Sweden (PPS). PPS focuses on the production and purification of (mainly) recombinant protein reagents for all Swedish researchers. The Director of PPS, Malin Bäckstr

https://www.lp3.lu.se/article/lp3-and-pps-35th-max-iv-user-meeting - 2025-10-03

LP3 is now part of "Pandemics and Alertness", a collaboration initiative for virus-related topics by Lund University Pandermics and Alertness is an interdisciplinary platform created to promote collaboration and change of information between stakeholders, researchers and experts from different disciplines, and public authorities to improve our knowledge of the impact of pandemics on the society. A

https://www.lp3.lu.se/article/pandemics-and-alertness - 2025-10-03

Together with DEMAX (see external wesite), the Lund Protein Production Platform (LP3) recently published a new protocol for the use of algal autolysate for the production of deuterium-labeled recombinant protein featuring:Continuous cultivation and autolysis of deuterated B. brauniiAutolysate used as glycerol substitute in recombinant protein productionUsing autolysate gives high protein yield and

https://www.lp3.lu.se/article/demax-and-lp3-publish-new-protocol-use-algal-autolysate-production-deuterium-labeled-recombinant - 2025-10-03